Key Highlights: Implications: Oncology ace Vanneste turbocharges MSD’s immuno-oncology push against Roche/Pfizer, targeting India’s exploding cancer caseload with ke...
Key Highlights: Implications: The appointment underlines ChemWerth’s intent to treat India not just as a sourcing base but as a strategic growth market for its re...
Latest Developments in Pharma Partnerships and Acquisitions India’s pharmaceutical industry has evolved into one of the most dynamic and globally integrated sectors in healthcare. As companies s...
